Dongyi Shen

No ORCID on file · 5 papers in corpus · active 2024-2026

Study types

  • article 2
  • other 1
  • preprint 1
  • review 1

Condition tags

  • endometriosis 4
  • mesh:D004715 2
  • infertility 2
article 2026
Network Pharmacology and Multi-omics Investigation of Yiqi HuoxueFormula’s Molecular Mechanisms in Treating Endometriosis
Combinatorial chemistry & high throughput screening ·doi:10.2174/0113862073397046251115102803

INTRODUCTION: Endometriosis (EMs), a prevalent disorder characterized by pelvic pain and infertility, affects numerous bodily systems and markedly diminishes life quality. Yiqi Huoxue formula (YQHXF) has demonstrated promising therapeutic e…

article 2026
Rubiadin, as a key metabolite of the Bushen Huoxue formula, promotes apoptosis of endometrial stromal cells and improves intrauterine adhesions by activating the AMPK/p53/p21 pathway
·doi:10.3389/fphar.2026.1732284

Background The Bushen Huoxue formula (BSHX) is a classic traditional Chinese medicine prescription for treating gynecological disorders. However, its specific metabolites and mechanisms against IUA remain to be elucidated. Aim This study ai…

other 2025
Endometriosis-related infertility in China: analysis of the global burden of disease study 2021
Frontiers in public health ·doi:10.3389/fpubh.2025.1651254

OBJECTIVE: Utilizing the Global Burden of Disease (GBD) 2021 dataset, this study analyzed temporal trends (1990-2021) and age-period-cohort patterns of endometriosis-related infertility burden in China versus globally. By employing joinpoin…

review 2025
Mitochondrial Involvement in the Pathogenesis of Endometriosis and its Potential as Therapeutic Targets
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-025-01827-5
preprint 2024
Global, regional, and national prevalence and disability-adjusted life-years for endometriosis in 204 countries and territories, 1990– 2019: findings from a global burden of disease study
·doi:10.21203/rs.3.rs-3857347/v1